CN110734925A
|
|
granulocyte or monocyte marking system and marking method and application thereof
|
CN105037548A
|
|
Anti-human interleukin-6 receptor [beta]-chain monoclonal antibody, preparation method and application thereof
|
CN103739707A
|
|
Humanized antibody for resisting avian influenza H5N1 hemagglutinin antigen, and preparation method and application thereof
|
CN102898521A
|
|
Anti-beta-interferon monoclonal antibody and its application
|
EP2540742A1
|
|
Anti-cyr61 protein monoclonal antibodies and uses thereof
|
CN102337262A
|
|
SiRNA for specific in vitro interference of expression of LAT protein in human T cell and application thereof
|
CN101709088A
|
|
Monoclonal antibody for resisting Cyr61 protein and application thereof
|
CN101709089A
|
|
Monoclonal antibody for resisting Cyr61 protein and application thereof
|
CN101708328A
|
|
Pharmaceutical application of CYR61 protein
|
CN102008716A
|
|
Application of beta-interferon to medicament making
|
CN102010892A
|
|
Method for evaluating effectiveness of beta-interferon for immunizing and intervening rheumatoid arthritis in vitro
|
CN101747435A
|
|
Monoclonal antibody (hybrid tumor) for neutralizing CYR61 and applications thereof
|
CN101619364A
|
|
Method for detecting HPV and application of Phi29DNA polymerase in detecting HPV
|